In addition, BCL11B enhancers may be hijacked by TLX1 and TLX3 in more mature T-cell malignancies (T-ALL), resulting in the overexpression of TLX1 and TLX3 [48]. This evidence concerns the gene TLX3 and acute lymphoblastic leukemia.